Compare, Analyse JUBILANT LIFE SCIENCES with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   ACTAVIS
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-19
ACTAVIS
Dec-18
JUBILANT LIFE SCIENCES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs89813,814-   
Low Rs6189,266-   
Sales per share (Unadj.) Rs572.03,388.6-  
Earnings per share (Unadj.) Rs36.2-1,091.5-  
Cash flow per share (Unadj.) Rs59.5357.1-  
Dividends per share (Unadj.) Rs4.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs301.913,976.2-  
Shares outstanding (eoy) m159.28332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.4 38.9%   
Avg P/E ratio x20.9-10.6 -197.8%  
P/CF ratio (eoy) x12.732.3 39.4%  
Price / Book Value ratio x2.50.8 304.0%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m120,6943,838,268 3.1%   
No. of employees `0002.416.9 14.1%   
Total wages/salary Rs m19,2600-   
Avg. sales/employee Rs Th38,120.666,688.4 57.2%   
Avg. wages/employee Rs Th8,058.40-   
Avg. net profit/employee Rs Th2,414.3-21,480.4 -11.2%   
INCOME DATA
Net Sales Rs m91,1081,127,034 8.1%  
Other income Rs m35721,553 1.7%   
Total revenues Rs m91,4661,148,587 8.0%   
Gross profit Rs m17,39029,534 58.9%  
Depreciation Rs m3,709481,783 0.8%   
Interest Rs m2,19865,036 3.4%   
Profit before tax Rs m11,840-495,732 -2.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,802126,432 -2.2%   
Tax Rs m3,268-6,282 -52.0%   
Profit after tax Rs m5,770-363,018 -1.6%  
Gross profit margin %19.12.6 728.4%  
Effective tax rate %27.61.3 2,177.9%   
Net profit margin %6.3-32.2 -19.7%  
BALANCE SHEET DATA
Current assets Rs m45,848462,250 9.9%   
Current liabilities Rs m20,897408,922 5.1%   
Net working cap to sales %27.44.7 578.8%  
Current ratio x2.21.1 194.1%  
Inventory Days Days5720 290.0%  
Debtors Days Days5166 76.8%  
Net fixed assets Rs m65,498127,574 51.3%   
Share capital Rs m1590-   
"Free" reserves Rs m47,9300-   
Net worth Rs m48,0894,648,488 1.0%   
Long term debt Rs m42,4291,636,901 2.6%   
Total assets Rs m114,6857,266,645 1.6%  
Interest coverage x6.4-6.6 -96.4%   
Debt to equity ratio x0.90.4 250.6%  
Sales to assets ratio x0.80.2 512.2%   
Return on assets %6.9-4.1 -169.4%  
Return on equity %12.0-7.8 -153.6%  
Return on capital %12.4-4.8 -256.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-4,8050-   
CASH FLOW
From Operations Rs m11,215402,647 2.8%  
From Investments Rs m-10,118221,202 -4.6%  
From Financial Activity Rs m6,574-691,062 -1.0%  
Net Cashflow Rs m7,612-66,878 -11.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.39 Rs / USD

Compare JUBILANT LIFE SCIENCES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare JUBILANT LIFE SCIENCES With: PIRAMAL ENTERPRISES  FULFORD INDIA  CADILA HEALTHCARE  J.B.CHEMICALS  STRIDES PHARMA SCIENCE  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views On News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Oct 17, 2019 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS